Comparison of Remogliflozin and Canagliflozin as Add-On Therapy in Indian Uncontrolled T2DM Subject

被引：0
|
作者：
Shankar, Anand
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1114-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1114-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy
    Kumar, Amit
    Prakash, Akhouri Sukrit
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2019, 34 (01): : 87 - 91
  • [2] Add-on to metformin in T2DM—linagliptin or glimepiride?
    Mikkel Christensen
    Filip K. Knop
    Nature Reviews Endocrinology, 2012, 8 : 576 - 578
  • [3] Remogliflozin in Indian T2DM Patients: A Real-World Study
    Bhattacharya, Supratik
    Katare, Sagar
    DIABETES, 2020, 69
  • [4] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    DIABETES, 2006, 55 : A111 - A111
  • [5] Initial Triple Combination Therapy Is Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed T2DM
    Abdul-Ghani, Muhammad A.
    Puckett, Curtiss
    Adams, John
    Cersosimo, Eugenio
    Triplitt, Curtis
    Defronzo, Ralph
    DIABETES, 2013, 62 : A18 - A18
  • [6] Initial Triple Combination Therapy Is Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed T2DM
    Abdul-Ghani, Muhammad A.
    Puckett, Curtiss
    Adams, John
    Cersosimo, Eugenio
    Triplitt, Curtis
    Defronzo, Ralph A.
    DIABETES, 2013, 62 : A97 - A98
  • [7] A Clinical Case Series of Use of SGLT2 Inhibitors as a Add-On Therapy in Patient with T2DM and HIV
    Reddy, Sowmya Chandra
    Bano, Kulsum
    Rozario, Papita
    Moore, William
    Warriner, Amy H.
    DIABETES, 2017, 66 : A632 - A632
  • [8] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
    Toplak, H
    Vercruysse, F
    Sun, X
    Fitchet, M
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159
  • [9] DAPAGLIFLOZIN: COST-EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES (T2DM) IN ARGENTINA AND CHILE
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Asteazaran, S.
    Aiello, E.
    Garrido Lecca, S.
    Alvarez, A.
    Roberts, M.
    Cortes Cuadra, P.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A248 - A248
  • [10] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
12345